Department of Family Medicine

Medicine & Life Sciences

1. Population 42%
2. Glucose 41%
3. Non-alcoholic Fatty Liver Disease 37%
4. Glucose Intolerance 29%
5. Sleep 28%
6. Fasting 28%
7. Obesity 26%
8. Insulin Resistance 25%
9. Hypertension 23%
10. Blood Pressure 22%
11. Body Mass Index 19%
12. Serum 19%
13. Prediabetic State 18%
14. Students 16%
15. Overweight 16%
16. Body Fat Distribution 16%
17. Diabetes Mellitus 16%
18. Lipids 16%
19. Ankle 16%
20. Arm 16%
21. Prehypertension 15%
22. Elderly 15%
23. alpha-2-HS-Glycoprotein 14%
24. HDL Cholesterol 14%
25. Confidence Intervals 14%
26. Orthostatic Hypotension 14%
27. Exercise 13%
28. Insulin 13%
29. Adipose Tissue 13%
30. Bone Density 12%
31. Gallstones 12%
32. Regression Analysis 12%
33. Streptozocin 12%
34. Cardiovascular Diseases 12%
35. Education 11%
36. Cross-Sectional Studies 11%
37. Cholesterol 10%
38. Logistic Models 10%
39. Odds Ratio 10%
40. Uric Acid 10%
41. Triglycerides 10%
42. Hypoglycemic Agents 10%
43. Magic 9%
44. Smoking 9%
45. Health 9%
46. Weights and Measures 9%
47. Quality of Life 8%
48. Cohort Studies 8%
49. Transitional Cell Carcinoma 8%
50. Esophagitis 8%
51. Depression 8%
52. Mastication 8%
53. Linear Models 8%
54. cardiotrophin 1 7%
55. Glycated Hemoglobin A 7%
56. Chronic Renal Insufficiency 7%
57. Dipeptidyl-Peptidase IV Inhibitors 7%
58. Kidney 7%
59. Waist-Hip Ratio 7%
60. Weight Loss 7%
61. Longitudinal Studies 7%
62. Areca 7%
63. Waist Circumference 7%
64. Alleles 7%
65. Randomized Controlled Trials 7%
66. Adiponectin 7%
67. Metformin 7%
68. Neuroticism 6%
69. SARS Virus 6%
70. Stroke 6%
71. Drinking 6%
72. Liver 6%
73. University Hospitals 6%
74. Fibrinogen 6%
75. Smokers 6%
76. Urine 6%
77. Adenoma 6%
78. Baroreflex 6%
79. Urologic Diseases 6%
80. Outpatients 6%
81. Cost-Benefit Analysis 6%
82. Dioxins 6%
83. Hepatocellular Carcinoma 6%
84. Cysts 6%
85. Neoplasms 5%
86. Costs and Cost Analysis 5%
87. Vaccination 5%
88. Social Support 5%